top of page
Syringe

Releases

MBK Healthcare Management to support Mitsui’s investment in Decoded Health

Jun.14, 2023

無題.png
MicrosoftTeams-image.png

MBK Healthcare Management Pte Ltd (“MHM”), a wholly owned subsidiary of Mitsui & Co., Ltd. (“Mitsui”) has supported Mitsui’s participation in a Series Seed Extension round of Decoded Health, Inc. (“Decoded”), a United States based health technology and digital medicine company. MHM will continue to support Mitsui through managing this investment.

Decoded has developed a first of its kind Clinical Hyperautomation Platform, leveraging explainable machine learning with Human-In-the-Loop Task Autonomy to automate patient conversations and augment the physician’s clinical workflow. Their platform automates clinical tasks with an end-to-end solution that can process and provide clinical inference and intelligent recommendations from patient interactions to the physician. This will help transform physician productivity and patient engagement. It functions as a virtual medical resident by processing and providing clinical inference from interactions with patient, providing intelligent recommendations to the physicians as well as fully automate documentation.

 

AI-enabled decision support solutions such as Decoded’s are increasingly important to alleviate the rising pressures in healthcare systems worldwide brought on by ageing populations, escalating healthcare costs and a healthcare workforce shortage.

 

Decoded’s focus on improving both the physician’s and the individual’s experience aligns this investment with Mitsui & MHM’s goal of transforming patient care and productivity of providers. MHM aims to facilitate collaborations between Mitsui’s existing portfolio companies and Decoded, as well as help Decoded expand their presence globally.

MHM was established in 2016 as Mitsui’s dedicated healthcare operating platform. As the largest shareholder of IHH Healthcare Berhad (IHH, KLSE: 5225, SGX: Q0F), a leading premium healthcare provider operating 80 hospitals in 10 countries with more than 15,000 licensed beds, MHM’s mission is to create long-term value and to grow the portfolio within the healthcare ecosystem of Mitsui.

bottom of page